Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GLAXOSMITHKLINE : UBS sticks Neutral

09/24/2021 | 06:36am EDT

UBS analyst Laura Sutcliffe maintains his Neutral opinion on the stock. The target price continues to be set at GBX 1460.


© MarketScreener with dpa-AFX Analyser 2021
All news about GLAXOSMITHKLINE PLC
10/21GLAXOSMITHKLINE : Says CDC Panel Voted to Recommend Approval of Shingles Vaccine Candidate
MT
10/20GLAXOSMITHKLINE : Shingles Vaccine Receives Recommendation in US for Immunocompromised Adu..
MT
10/20Glaxosmithkline plc Announces Unanimous Votes of US Centers for Disease Control and Pre..
CI
10/20GLAXOSMITHKLINE : US Centers for Disease Control and Prevention's Advisory Committee on Im..
PU
10/20GLAXOSMITHKLINE : Viom, GlaxoSmithKline Expand Collaboration Into New Cancer, Autoimmune D..
MT
10/20LESS TALK, MORE ACTION : New report sponsored by ViiV Healthcare provides roadmap to achie..
PU
10/20Viome Life Sciences Announces Expansion of Collaboration with GSK into New Therapeutic ..
CI
10/19'Green is good' says UK's Johnson, wooing Wall Street dollars
RE
10/19Pharnext renforce son équipe de direction avec trois nominations clés pour poursuivre l..
DJ
10/19Pharnext strengthens its management team with three key appointments to support ongoing..
DJ
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 519 M 46 115 M 46 115 M
Net income 2021 3 787 M 5 210 M 5 210 M
Net Debt 2021 21 074 M 28 993 M 28 993 M
P/E ratio 2021 18,6x
Yield 2021 5,63%
Capitalization 71 110 M 97 886 M 97 833 M
EV / Sales 2021 2,75x
EV / Sales 2022 2,58x
Nbr of Employees 94 066
Free-Float 92,3%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 420,80 GBX
Average target price 1 602,73 GBX
Spread / Average Target 12,8%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC5.87%97 886
JOHNSON & JOHNSON4.03%430 990
ROCHE HOLDING AG15.15%337 974
NOVO NORDISK A/S58.77%242 392
PFIZER, INC.16.44%241 985
ELI LILLY AND COMPANY44.37%220 979